Pra Health Sciences Inc (PRAH) Growth Rates Comparisons to Medical Laboratories Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Pra Health Sciences Inc   (NASDAQ: PRAH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Pra Health Sciences Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRAH Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 19.15 % 35.38 % 15.08 % 14.89 %
Q / Q Revenue Growth (Q1 MRQ) 6.91 % -1.77 % -2.3 % 2.02 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 6.57 % 22.59 % 6.93 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 4.71 % 7.94 % 3.56 % 3.64 %
Revenue 5 Year Average Growth 14.55 % 21.64 % 10.85 % 9.03 %


PRAH's Growth Comparisons in I. Quarter 2021




Pra Health Sciences Inc improved it's Revenue by 19.15% from the same quarter a year ago, in the first quarter 2021, and underperformed the 35.38% improvement in the Medical Laboratories industry, but beating the 15.08% improvement in the Healthcare sector. Above the average sales gains in the Healthcare and in the Medical Laboratories industry as well, helped to elevate overall market growth to 14.89%.

Comparing the company's Revenue to the fourth quarter results, sales were higher by 6.91% . On the yearly basis, average annual sales growth for Pra Health Sciences Inc is 14.55%, while S & P 500's including only Businesses with the first quarter 2021 earnings, average annual sales growth is 9.03% over the past five years.


Growth Rates of PRAH's Income in the first quarter 2021


PRAH Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) 10.02 % - 32.5 % 92.71 %
Sequential Operating Income Change (Q1 MRQ) -28.43 % -11.63 % 83.38 % 58.11 %
Y / Y Operating Income Growth (Q1 TTM) -4.01 % 177.98 % -12.74 % -6.23 %
Sequential Operating Income Growth (Q1 TTM) 1.93 % 53.85 % 9.28 % 19.42 %
Operating Income 5 Year Avg. Change 14.83 % 13.4 % 2.2 % 8.2 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 40.04 % - 44.46 % 153.38 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) 11.09 % -53.45 % 144.66 % 61.73 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) -10.94 % 734.07 % -13.56 % 0.07 %
Sequential Income from Cont. Ops. Change (Q1 TTM) 8.26 % 37.1 % 15.74 % 28.52 %
Income from Cont. Ops. 5 Year Avg. Change 19.23 % 16.52 % 10.33 % 76.07 %

PRAH Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 40.04 % - 39.36 % 144.01 %
Q / Q Net Income Growth (Q1 MRQ) 11.09 % - 654.36 % 64.84 %
Y / Y Net Income Change (Q1 TTM) -10.94 % 756.26 % -19.18 % -0.39 %
Sequential Net Income Change (Q1 TTM) 8.26 % 85.74 % 17.16 % 27.86 %
Net Income 5 Year Avg. Growth 19.23 % 16.06 % 1.77 % 4.21 %

PRAH's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 36.92 % - 44.46 % 153.38 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) 9.88 % -57.66 % 144.66 % 61.73 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) -9.68 % - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) 7.69 % - - 34.47 %
EPS from Cont. Ops. 5 Year Avg. Growth 17.99 % 21.77 % 10.33 % 76.07 %



PRAH EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 36.51 % - 39.36 % 76.07 %
Q / Q EPS Net Growth (Q1 MRQ) 8.86 % - 654.36 % 64.84 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - -27.73 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) 7.54 % - - 32.32 %
EPS Net 5 Year Avg. Change 18.7 % 16.06 % 1.77 % 4.21 %



With 36.51% year on year EPS increase in the first quarter, Pra Health Sciences Inc outperformed the 35.38% improvement in the Medical Laboratories industry, but Pra Health Sciences Inc 's growth compares unfavorably, to the 39.36% EPS increase in the Healthcare sector.

Comparing company's EPS to the fourth quarter results, income per share were higher by 8.86% . On the yearly basis, average annual income per share growth for Pra Health Sciences Inc is 18.7%, while S & P 500's including only the businesses with the first quarter 2021 Results, average annual income per share growth is 4.21% over the past five years.

PRAH Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) 343.41 % - 101.87 % 156.25 %
Sequential Free Cash Flow Change (Q1 MRQ) 17.77 % -6.41 % -24.35 % -39.04 %
Y / Y Free Cash Flow Change (Q1 TTM) 150.79 % 204.6 % 40.36 % -12.8 %
Sequential Free Cash Flow Change (Q1 TTM) 37.28 % 62.31 % 10.43 % 8.85 %
Free Cash Flow 5 Year Avg. Change - 26.51 % 14.45 % 20.95 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - -84.63 % -75.89 %
Sequential Net Cash Flow Change (Q1 MRQ) 8.16 % -40.42 % - -1.91 %
Y / Y Net Cash Flow Change (Q1 TTM) - 561.74 % - 12.22 %
Sequential Net Cash Flow Change (Q1 TTM) - 32.58 % - -43.24 %
Net Cash Flow 5 Year Avg. Change 30.21 % - 45.88 % 111.43 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -12.7 % 8.69 % 6.55 % 1.87 %
Sequential Capital Expenditures Change (Q1 MRQ) 46.54 % -34 % -27.85 % -22.75 %
Y / Y Capital Expenditures Change (Q1 TTM) -15.52 % 6.5 % 2.01 % -10.89 %
Sequential Capital Expenditures Change (Q1 TTM) -4.08 % 2.46 % 1.16 % 0.11 %
Capital Expenditures 5 Year Avg. Change - 17.83 % 11.27 % 9.31 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.